ArticleScientific reports2026
Cellular and subcellular localization of the copper transporter CTR1 in human postmortem hippocampus and striatum.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Copper is essential for neurological function, and its transport across the blood-brain barrier (BBB) is mediated by the copper transporter CTR1. Via CTR1, copper enters endothelial cells at the BBB and is transported into astrocytes and neurons. Although critical for homeostasis, copper distribution varies across brain regions and within cells. Knockdown of CTR1 causes developmental defects, highlighting its significance. This study examined CTR1 localization in human postmortem hippocampus and striatum. Postmortem brain samples from unaffected individuals were analyzed using immunohistochemistry, in situ hybridization, and ultrastructural electron microscopy (EM). Immunolabeling was observed in putative endothelial-like, astrocytic-like and oligodendroglial-likeprofiles, pyramidal neurons, and bipolar-appearing interneuronal profiles. Multiplex fluorescent in situ hybridization demonstrated SLC31A1 mRNA signal in neuronal, vascular-associated, and glial-associated cellular populations corresponding to those identified by immunohistochemistry. Using ultrastructural EM, CTR1-associated labeling was observed in axon terminals forming asymmetric synapses in the hippocampus and striatum, including labeling adjacent to vesicular structures. Additionally, CTR1-associated labeling was observed adjacent to mitochondrial profiles in both regions. These findings provide descriptive baseline data on CTR1 localization in human brain and may inform future studies of copper transport in health and disease. disorders.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.